Genistein exhibits anti-cancer effects via down-regulating FoxM1 in H446 small-cell lung cancer cells

Tumor Biology

Volumn 35, Issue 5, 2014, Pages 4137-4145

  Tian, Tiantian ^a   Li, Jisheng ^a   Li, Bei ^a   Wang, Yawei ^a   Li, Meiying ^a   Ma, Daoxin ^a   Wang, Xiuwen ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle arrest; FoxM1; Genistein; SCLC

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; CYCLIN B1; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; GENISTEIN; MESSENGER RNA; SURVIVIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FOXM1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DNA TRANSFECTION; DOSE TIME EFFECT RELATION; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE TARGETING; HUMAN; HUMAN CELL; LUNG CANCER CELL LINE; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SOYBEAN; WESTERN BLOTTING; WOUND HEALING ASSAY; CELL MOTION; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; LUNG TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CISPLATIN; FORKHEAD TRANSCRIPTION FACTORS; GENISTEIN; HUMANS; LUNG NEOPLASMS; SMALL CELL LUNG CARCINOMA;

EID: 84902995767     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1542-0     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Sher T, Dy GK, Adjei AA. Small cell lung cancer. Mayo Clin Proc. 2008;83:355-67. (Pubitemid 351471707)
3. Lampe JW, Nishino Y, Ray RM, Wu C, Li W, Lin MG. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in shanghai, china. Cancer Epidemiol Biomarkers Prev. 2007;16:2579-86. (Pubitemid 351196312)
4. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007;16:538-45. (Pubitemid 46548658)
5. Li Q, Chen H. Epigenetic modifications of metastasis suppressor genes in colon cancer metastasis. Epigenetics. 2011;6:849-52.
6. Sarkar FH, Li Y. The role of isoflavones in cancer chemoprevention. Front Biosci. 2004;9:2714-24.
7. Zhang Y, Li Q, Zhou D, Chen H. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of wnt/beta-catenin signalling and reduces colon pre-neoplasia in rats. Br J Nutr. 2013;109:33-42.
8. Gadgeel SM, Ali S, Philip PA, Wozniak A, Sarkar FH. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa b in nonsmall cell lung cancer cell lines. Cancer. 2009;115:2165-76.
9. Yamasaki M, Mine Y, Nishimura M, Fujita S, Sakakibara Y, Suiko M, et al. Genistein induces apoptotic cell death associated with inhibition of the nf-kappab pathway in adult t-cell leukemia cells. Cell Biol Int. 2013;37:742-7.
10. Li Y, Che M, Bhagat S, Ellis KL, Kucuk O, Doerge DR, et al. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia. 2004;6:354-63. (Pubitemid 38924850)
11. Liang C, Li H, Shen C, Lai J, Shi Z, Liu B, et al. Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of akt and nuclear factor-kappab pathway. Anticancer Agents Med Chem. 2012;12:554-63.
12. Lattrich C, Lubig J, Springwald A, Goerse R, Ortmann O, Treeck O. Additive effects of trastuzumab and genistein on human breast cancer cells. Anticancer Drugs. 2011;22:253-61.
13. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005;65:9064-72. (Pubitemid 41377399)
14. Shimazu T, Inoue M, Sasazuki S, Iwasaki M, Sawada N, Yamaji T, et al. Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev. 2011;20:419-27.
15. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-63. (Pubitemid 28513713)
16. Zhou Y, Lee AS. Mechanism for the suppression of the mammalian stress response by genistein, an anticancer phytoestrogen from soy. J Natl Cancer Inst. 1998;90:381-8. (Pubitemid 28131006)
17. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592-5.
18. Li Y, Sarkar FH. Inhibition of nuclear factor kappab activation in pc3 cells by genistein is mediated via akt signaling pathway. Clin Cancer Res. 2002;8:2369-77. (Pubitemid 34753612)
19. Wang Z, Ahmad A, Banerjee S, Azmi A, Kong D, Li Y, et al. Foxm1 is a novel target of a natural agent in pancreatic cancer. Pharm Res. 2010;27:1159-68.
20. KorverW, Roose J, Clevers H. The winged-helix transcription factor trident is expressed in cycling cells. Nucleic Acids Res. 1997;25:1715-9. (Pubitemid 27303351)
21. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, et al. Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the scf (skp2-cks1) ubiquitin ligase. Mol Cell Biol. 2005;25:10875 - 94.
22. Green MR, Aya-Bonilla C, Gandhi MK, Lea RA, Wellwood J, Wood P, et al. Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-hodgkin's lymphoma. Gene Chromosome Cancer. 2011;50:313-26.
23. Uddin S, Ahmed M, Hussain A, Abubaker J, Al-Sanea N, AbdulJabbar A, et al. Genome-wide expression analysis of middle eastern colorectal cancer reveals foxm1 as a novel target for cancer therapy. Am J Pathol. 2011;178:537-47.
24. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, et al. Critical role and regulation of transcription factor foxm1 in human gastric cancer angiogenesis and progression. Cancer Res. 2009;69:3501-9.
25. Ahmad A, Wang Z, Kong D, Ali S, Li Y, Banerjee S, et al. Foxm1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extracellular matrix degrading factors. Breast Cancer Res Treat. 2010;122:337-46.
26. Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, et al. Foxm1 promotes beta-catenin nuclear localization and controls wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011;20:427-42.
27. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of forkhead box m1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res. 2007;67:8293-300. (Pubitemid 47395167)
28. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature. 2004;432:316-23. (Pubitemid 39551659)
29. Kasibhatla S, Tseng B. Why target apoptosis in cancer treatment? Mol Cancer Ther. 2003;2:573-80.
30. Laoukili J, KooistraMR, Bras A, Kauw J, Kerkhoven RM, Morrison A, et al. Foxm1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126-36. (Pubitemid 40268127)
31. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A. 2004;101:9309-14. (Pubitemid 38812872)
32. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R. Identification and validation of commonly overexpressed genes in solid tumors by comparison of microarray data. Neoplasia. 2004;6:744-50. (Pubitemid 40041492)
33. Park HJ, Gusarova G, Wang Z, Carr JR, Li J, Kim KH, et al. Deregulation of foxm1b leads to tumour metastasis. EMBO Mol Med. 2011;3:21-34.
34. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, et al. Foxm1b transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res. 2008;68:8733-42.
35. Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, et al. Aberrant foxm1b expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene. 2007;26:6212-9. (Pubitemid 47414378)
36. Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, et al. Array-based comparative genomic hybridization identifies cdk4 and foxm1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res. 2011;17:1924-34.
37. PrillerM, Poschl J, Abrao L, von Bueren AO, Cho YJ, Rutkowski S, et al. Expression of foxm1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clin Cancer Res. 2011;17:6791-801.
38. Hui MK, Chan KW, Luk JM, Lee NP, Chung Y, Cheung LC, et al. Cytoplasmic forkhead box m1 (foxm1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg. 2012;36:90-7.